Data-driven research in vital life sciences fields is more important than ever as the COVID-19 pandemic continues to spread its way into a second year of impacting people’s day-to-day affairs, not only in the United States but throughout the world. Dynamic Global Events’ (DGE’s) two-day Real-World Evidence & Market Access Symposium, which kicked off April 14 as a live-streamed gathering of research experts and commercial interests, addressed the disruptive forces that are changing how real-world evidence (RWE) is being used and impacting people’s lives on a large scale. RWE is yielding significant advances in health care, and this month’s gathering of experts is a relevant event at a relevant time.
The symposium featured more than two dozen speaking faculty members hailing from research universities and international corporations, including Pfizer’s North American vice president over its rare diseases segment. The speakers will tackle topics such as how to gauge the unprecedented impact of RWE during the COVID-19 pandemic and what to expect in the future, regulatory insight on FDA initiatives to optimize RWE in labeling, utilizing real-world data to identify hidden market insights, and applying RWE to communications strategies, among its series of subjects.
For more information, visit the symposium’s web portal at https://dgevents.com/event/real-world-evidence-market-access-symposium/.